HUE039551T2 - Metabolikusan optimalizált sejttenyészet - Google Patents

Metabolikusan optimalizált sejttenyészet

Info

Publication number
HUE039551T2
HUE039551T2 HUE14851841A HUE14851841A HUE039551T2 HU E039551 T2 HUE039551 T2 HU E039551T2 HU E14851841 A HUE14851841 A HU E14851841A HU E14851841 A HUE14851841 A HU E14851841A HU E039551 T2 HUE039551 T2 HU E039551T2
Authority
HU
Hungary
Prior art keywords
cell culture
optimized cell
metabolically optimized
metabolically
culture
Prior art date
Application number
HUE14851841A
Other languages
English (en)
Hungarian (hu)
Inventor
Shawn Lawrence
Ann Kim
Amy Johnson
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52813657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE039551(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HUE039551T2 publication Critical patent/HUE039551T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/60Buffer, e.g. pH regulation, osmotic pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
HUE14851841A 2013-10-11 2014-10-10 Metabolikusan optimalizált sejttenyészet HUE039551T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361889815P 2013-10-11 2013-10-11

Publications (1)

Publication Number Publication Date
HUE039551T2 true HUE039551T2 (hu) 2019-01-28

Family

ID=52813657

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE14851841A HUE039551T2 (hu) 2013-10-11 2014-10-10 Metabolikusan optimalizált sejttenyészet
HUE18161278A HUE051049T2 (hu) 2013-10-11 2014-10-10 Metabolikusan optimalizált sejttenyészet

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE18161278A HUE051049T2 (hu) 2013-10-11 2014-10-10 Metabolikusan optimalizált sejttenyészet

Country Status (17)

Country Link
US (2) US20160244725A1 (enExample)
EP (3) EP3351620B1 (enExample)
JP (3) JP6663854B2 (enExample)
KR (4) KR102358807B1 (enExample)
CN (2) CN114717196A (enExample)
AU (2) AU2014331776B2 (enExample)
CA (1) CA2926049C (enExample)
DK (2) DK3055409T3 (enExample)
EA (2) EA033783B1 (enExample)
ES (2) ES2833471T3 (enExample)
HU (2) HUE039551T2 (enExample)
IL (2) IL244511A0 (enExample)
MX (2) MX376623B (enExample)
PL (2) PL3055409T3 (enExample)
SG (2) SG10201800772TA (enExample)
WO (1) WO2015054554A1 (enExample)
ZA (1) ZA201601550B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3055409T3 (pl) 2013-10-11 2018-10-31 Regeneron Pharmaceuticals, Inc. Metabolicznie zoptymalizowana hodowla komórkowa
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US20160244726A1 (en) * 2013-10-11 2016-08-25 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
JP7260011B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260020B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260018B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260013B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7310952B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7310945B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7260009B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260012B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260021B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7272480B2 (ja) * 2017-04-27 2023-05-12 株式会社三洋物産 遊技機
JP7310947B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
WO2019071076A1 (en) 2017-10-06 2019-04-11 Lonza Ltd. AUTOMATED CONTROL OF CELL CULTURE BY SPECTROSCOPY RAMAN
EP3697887B1 (en) 2017-10-16 2022-04-06 Regeneron Pharmaceuticals, Inc. Perfusion methods
EP3717656B1 (en) * 2017-11-30 2024-03-13 F. Hoffmann-La Roche AG Process for culturing mammalian cells
BR112020019726A2 (pt) * 2018-03-29 2021-01-26 Genentech, Inc. células de mamífero, composição, métodos para reduzir ou eliminar a atividade lactogênica em uma célula, para produzir um produto de interesse e para cultivar uma população
GB201810772D0 (en) 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
JP7231355B2 (ja) * 2018-08-22 2023-03-01 日機装株式会社 細胞培養方法および細胞培養装置
CA3100035A1 (en) 2018-08-27 2020-03-05 Regeneron Pharmaceuticals, Inc. Use of raman spectroscopy in downstream purification
JP2020151559A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
JP2020151560A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
EP3985097A1 (en) * 2020-10-14 2022-04-20 Sartorius Stedim Biotech GmbH A method and system for configuring and/or setup of a downstream process for processing a biomass

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
KR970029803A (ko) 1995-11-03 1997-06-26 김광호 반도체 메모리장치의 프리차지 회로
US6165741A (en) 1997-05-30 2000-12-26 The Trustees Of The University Of Pennsylvania Method for rapid detection of bacterial growth in cultures
US5972650A (en) 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
AU2002245272B2 (en) 2001-01-16 2006-06-29 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US7039770B1 (en) 2002-03-05 2006-05-02 Juniper Networks, Inc. Low latency request dispatcher
CA2417689C (en) 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Improved methods for growing mammalian cells in vitro
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
EP1623019B2 (en) 2003-05-15 2017-01-25 Wyeth LLC Restricted glucose feed for animal cell culture
US7531327B2 (en) * 2004-07-23 2009-05-12 Immunomedics, Inc. Methods and compositions for increasing longevity and protein yield from a cell culture
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
TWI364458B (en) * 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
WO2007056062A2 (en) * 2005-11-02 2007-05-18 Wyeth Methods for adapting mammalian cells
KR101866623B1 (ko) 2005-11-28 2018-07-04 젠맵 에이/에스 재조합 1가 항체 및 그의 제조 방법
US7575890B2 (en) 2006-01-18 2009-08-18 Oxygen Enterprises, Ltd. Method for rapid detection and evaluation of cultured cell growth
US8192951B2 (en) 2006-11-03 2012-06-05 Wyeth Llc Glycolysis-inhibiting substances in cell culture
WO2008151219A1 (en) 2007-06-04 2008-12-11 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
WO2009023562A2 (en) 2007-08-09 2009-02-19 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
WO2009152413A1 (en) * 2008-06-13 2009-12-17 Centocor Ortho Biotech Inc. Methods for obtaining high viable cell density in mammalian cell culture
US8470552B2 (en) * 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
PL2563904T3 (pl) * 2010-04-26 2015-06-30 Novartis Ag Udoskonalona pożywka do hodowli komórkowej
KR101869987B1 (ko) * 2010-05-28 2018-07-20 제넨테크, 인크. 락테이트 데히드로게나제 및 피루베이트 데히드로게나제 키나제의 발현의 하향조절에 의한 락테이트 수준의 감소 및 폴리펩티드 생산의 증가
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
US20150353542A1 (en) * 2013-01-14 2015-12-10 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
PL3055409T3 (pl) 2013-10-11 2018-10-31 Regeneron Pharmaceuticals, Inc. Metabolicznie zoptymalizowana hodowla komórkowa

Also Published As

Publication number Publication date
AU2021200193B2 (en) 2023-08-24
KR20230038324A (ko) 2023-03-17
KR20160062032A (ko) 2016-06-01
JP7377243B2 (ja) 2023-11-09
AU2014331776A1 (en) 2016-03-24
EA033783B1 (ru) 2019-11-25
HK1223122A1 (en) 2017-07-21
WO2015054554A1 (en) 2015-04-16
EA201690600A1 (ru) 2016-09-30
MX2020011334A (es) 2021-07-30
KR102358807B1 (ko) 2022-02-08
ES2833471T3 (es) 2021-06-15
JP6967620B2 (ja) 2021-11-17
EP3055409A1 (en) 2016-08-17
US20160244725A1 (en) 2016-08-25
HK1253275A1 (en) 2019-06-14
ES2678945T3 (es) 2018-08-21
EP3351620A1 (en) 2018-07-25
CA2926049A1 (en) 2015-04-16
HUE051049T2 (hu) 2021-01-28
JP2020072760A (ja) 2020-05-14
KR102510238B1 (ko) 2023-03-16
DK3351620T3 (da) 2020-10-26
AU2021200193A1 (en) 2021-03-18
PL3055409T3 (pl) 2018-10-31
EA201991976A1 (ru) 2020-04-02
CA2926049C (en) 2023-09-05
US20210087535A1 (en) 2021-03-25
DK3055409T3 (en) 2018-07-30
AU2014331776B2 (en) 2020-10-22
IL244511A0 (en) 2016-04-21
KR20210046835A (ko) 2021-04-28
MX384960B (es) 2025-03-14
JP2016532457A (ja) 2016-10-20
SG10201800772TA (en) 2018-03-28
KR102243980B1 (ko) 2021-04-26
JP2022009453A (ja) 2022-01-14
KR102610425B1 (ko) 2023-12-06
MX376623B (es) 2025-03-07
ZA201601550B (en) 2023-05-31
JP6663854B2 (ja) 2020-03-13
KR20220020415A (ko) 2022-02-18
MX2016004564A (es) 2016-07-12
EP3055409A4 (en) 2016-09-28
EP3351620B1 (en) 2020-09-02
CN114717196A (zh) 2022-07-08
EP3055409B1 (en) 2018-04-25
PL3351620T3 (pl) 2021-03-08
IL262833A (en) 2018-12-31
SG11201601681QA (en) 2016-04-28
EP3812453A1 (en) 2021-04-28
CN105637085A (zh) 2016-06-01

Similar Documents

Publication Publication Date Title
IL262833A (en) Metabolically enriched cell culture
IL245573A0 (en) cell
EP2971014A4 (en) CELL CULTURE METHODS
EP2971040A4 (en) CELL CULTURE METHODS
SG11201500417PA (en) Cell culture
SG11201509558VA (en) Back-contact-type solar cell
EP2961825A4 (en) STRUCTURE FOR CULTIVATION OF CELLS
IL245392A0 (en) A method for cell culture
GB201318262D0 (en) Sram Cells
GB201420277D0 (en) Cell culture system
PL2970845T3 (pl) Bioreaktor
GB201310031D0 (en) Cell
GB201312332D0 (en) Cell locations
GB201306326D0 (en) Fuel cells
PL2978839T3 (pl) Sposób hodowli komórek
GB201307880D0 (en) Fuel cells
GB201211873D0 (en) Cell culture
SG11201507338PA (en) Method for culturing cells
GB201317614D0 (en) Fuel cell
GB201518180D0 (en) Fuel cell
GB201308905D0 (en) Cell culture
GB201306488D0 (en) Cell culture
GB201317589D0 (en) Cell
GB201320573D0 (en) T Cell
GB201303132D0 (en) Cell Line